Trends and Forecast Analysis of the Evicel Market Highlight Significant Long-Term Growth Potential

The Business Research Company

Evicel Market

The Business Research Company’s Evicel Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 4, 2026 /EINPresswire.com/ -- Understanding the Evicel Market’s Growth and Dynamics
The Evicel market is evolving steadily, driven by a combination of clinical needs and surgical advancements. As healthcare continues to prioritize patient safety and surgical efficiency, the demand for effective hemostatic agents like Evicel has grown. Let’s explore the market’s current value, the key factors influencing its expansion, prominent regional trends, and the main sectors contributing to its development.

Exploring the Size and Growth Trajectory of the Evicel Market
Historically, the Evicel market has expanded due to the high risks of bleeding during surgeries, the limitations of mechanical methods to control bleeding, wider acceptance of plasma-derived products, the rise in complex surgical procedures, and an overall focus on improving patient safety. Looking ahead, this growth is expected to continue as minimally invasive surgeries become more common, surgical volumes increase, specialty clinics expand, innovations in surgical biomaterials advance, and surgical efficiency remains a priority. Key trends shaping the market include the growing use of fibrin sealants during surgery, demand for biocompatible hemostatic agents, rise in cardiovascular and liver operations, preference for human plasma-based sealants, and the broadening of advanced surgical techniques.

Download a free sample of the evicel market report:
https://thebusinessresearchcompany.com/sample_request?id=96490121&type=smp&name=Evicel%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

The Role of Evicel in Surgical Hemostasis
Evicel is a fibrin sealant composed of human fibrinogen and thrombin that helps control bleeding and supports healing by promoting clot formation during surgery. It is widely used in procedures requiring meticulous bleeding control such as cardiovascular, liver, and orthopedic surgeries. Because of its biological compatibility, Evicel minimizes the risk of adverse reactions, making it a safe option for patients needing precise surgical bleeding management.

Rising Prevalence of Bleeding Disorders Boosting Evicel Demand
One of the main drivers of Evicel’s market growth is the increasing prevalence of bleeding disorders. These conditions impair the blood’s ability to clot properly, leading to excessive or prolonged bleeding after injury or surgery. Factors contributing to the rise in bleeding disorders include genetic conditions like hemophilia, lifestyle influences such as poor nutrition and obesity, and the increasing incidence of chronic diseases affecting coagulation, such as liver disorders. Evicel is particularly effective in managing bleeding in patients with clotting deficiencies or coagulation challenges. For example, in May 2025, Pfizer Inc. reported that the haemophilia A and B patient population in the UK exceeded 11,800 individuals during 2023/2024. This rising prevalence of bleeding disorders is expected to continue driving demand for Evicel.

View the full evicel market report:
https://thebusinessresearchcompany.com/report/evicel-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Impact of Chronic Diseases on the Expanding Evicel Market
The growing number of chronic diseases is also playing a significant role in expanding the Evicel market. Chronic illnesses, such as diabetes and heart disease, typically last a year or more and require ongoing care, often affecting patients’ ability to heal and clot normally. Factors like aging populations, unhealthy lifestyles, environmental influences, and improved diagnostics contribute to the increasing incidence of these conditions. Evicel’s use in surgical procedures helps control bleeding and reduce complications in patients with chronic disorders. For instance, data from the UK’s Office for Health Improvement & Disparities in March 2024 showed substantial improvements in diabetes care outcomes between 2022 and 2023, including a 22% increase in patients receiving all recommended care processes for type 1 diabetes and a 21% rise for type 2 diabetes. Such trends highlight the growing need for effective surgical hemostats like Evicel.

Increasing Popularity of Aesthetic Surgeries Driving Market Demand
Another important factor fueling Evicel’s growth is the rising demand for aesthetic surgeries. These procedures, which can be minimally invasive or non-invasive, aim to enhance appearance by improving skin texture and reducing signs of aging such as wrinkles and sagging. The surge in aesthetic treatments is influenced by higher incomes, aging populations, social media trends, and advances in cosmetic technology. Evicel plays an important role in these surgeries by aiding wound closure and minimizing postoperative complications, thereby reducing scarring and promoting better healing. For example, according to the International Society of Aesthetic Plastic Surgery in June 2024, total aesthetic procedures increased by 3.4% in 2023, reaching 34.9 million, with face and head procedures growing by nearly 20% to over 6.5 million cases. This growing interest in cosmetic surgeries is positively impacting the Evicel market.

Regional Insights Highlighting Evicel Market Trends
In 2025, North America remained the largest market for Evicel, driven by advanced healthcare infrastructure and high adoption rates of innovative surgical products. Meanwhile, the Asia-Pacific region is projected to be the fastest-growing market during the forecast period. This report covers key geographic regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive view of global market trends and opportunities.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+ +44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X